[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Page 19594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05777]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Sole Source Cooperative Agreement To Fund 
National Health Laboratory Service (NHLS)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award(s) of approximately $5,000,000, for Year 1 funding to NHLS. 
The(se) award(s) will strengthen laboratory systems for improved access 
to sustainable delivery of quality laboratory services and promote 
rational use of diagnostic services in South Africa through above site 
interventions. Funding amounts for years 2-5 will be set at 
continuation.

DATES: The period for this award will be September 30, 2024, through 
September 29, 2029.

FOR FURTHER INFORMATION CONTACT: Artur Ramos, Center for Global Health, 
Centers for Disease Control and Prevention, 100 Totius Street, 
Groenkloof, Pretoria, telephone: 3108483712, e-Mail: [email protected].

SUPPLEMENTARY INFORMATION: The(se) sole source award(s) will address 
gaps in line with PEPFAR strategies and the Government of South 
Africa's key priority areas that need continued PEPFAR support. This 
includes developing and reviewing laboratory policies, strategic plans, 
and governance structures to expand diagnostic health equity and 
response to Human Immunodeficiency Virus (HIV), Tuberculosis (TB) and 
related public health needs. It also includes prioritizing technical 
and systems advancements to increase operational efficiencies and 
improve service delivery as well as supporting an environment that 
facilitates and endorses integration, ownership, and sustainable 
transition of PEPFAR-funded laboratory activities to NHLS and the 
National Department of Health.
    NHLS is in a unique position to conduct this work, as it is the 
sole provider of diagnostic pathology services to the public sector in 
South Africa and has been mandated by the government of South Africa 
under the National Health Laboratory Service Act, 2000 to provide 
quality, affordable, and sustainable laboratory and related public 
health services. Quality laboratory testing is an essential building 
block of the HIV clinical cascade as accurate and timely clinical 
laboratory services will facilitate the earlier diagnosis of HIV, 
staging, identification of adverse drug events and opportunistic 
infections, and monitoring the response of individual patients to 
therapy, including identification of treatment failures.

Summary of the Award

    Recipient: National Health Laboratory Service (NHLS).
    Purpose of the Award: The purpose of this award is to strengthen 
laboratory systems for improved access to sustainable delivery of 
quality laboratory services and promote rational use of diagnostic 
services in South Africa through above site interventions.
    Amount of Award: For NHLS, the approximate year 1 funding amount 
will be $5,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Public Law 108-25 (the 
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act 
of 2003) (22 U.S.C. 7601, et seq.) and Public Law 110-293 (the Tom 
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and 
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013). 
Additionally, this program is authorized under section 307 of the 
Public Health Service Act (42 U.S.C. 242l), as amended and section 
301(a) of the Public Health Service Act (42 U.S.C. 241(a)), as amended.
    Period of Performance: The period for this award will be September 
30, 2024, through September 29, 2029.

    Dated: March 13, 2024.
Jamie Legier
Acting Director, Office of Grants Services, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-05777 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P